Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gerris

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
Human Reproduction (Oxford, England)|November 1, 1989
Comparison of HMG/HCG superovulation for AID with or without superactive GnRH agonistJ Gerris, Y Jacquemyn, E Desmedt, et al.
Fertility and Sterility|March 1, 1991
Placebo-controlled trial of high-dose Mesterolone treatment of idiopathic male infertilityJ Gerris, F Comhaire, P Hellemans, et al.
Facts, Views & Vision in Obgyn|December 7, 2017
Correlation between saliva and serum concentrations of estradiol in women undergoing ovarian hyperstimulation with gonadotropins for IVF/ICSIC Dielen, T Fiers, S Somers, et al.
Human Reproduction (Oxford, England)|August 10, 2004
Placenta percreta causing rupture of an unscarred uterus at the end of the first trimester of pregnancy: case reportA Esmans, J Gerris, E Corthout, et al.
Human Reproduction (Oxford, England)|October 1, 1993
Triggering of ovulation using a gonadotrophin-releasing hormone agonist does not prevent ovarian hyperstimulation syndromeS van der Meer, J Gerris, M Joostens, et al.
Human Reproduction (Oxford, England)|January 1, 1995
Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU)J Gerris, A De Vits, M Joostens, et al.
Acta Anaesthesiologica Belgica|June 1, 1983
Anesthesiological problems related to the use of beta-sympathomimetic drugs for chronic and acute tocolysisJ Gerris, G Van Den Abeele, A M Behiels, et al.
Facts, Views & Vision in Obgyn|April 23, 2014
Prevalence of chromosomal abnormalities and timing of karyotype analysis in patients with recurrent implantation failure (RIF) following assisted reproductionP De Sutter, R Stadhouders, M Dutré, et al.
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|March 22, 2003
[Prevention of twin pregnancy after IVF/ICSI using embryo transfer]D De Neubourg, J Gerris, E Van Royen, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|September 9, 2009
Cytology of the 'penile' neovagina in transsexual womenS Weyers, K Lambein, Y Sturtewagen, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Human Reproduction (Oxford, England)|November 1, 1989
Comparison of HMG/HCG superovulation for AID with or without superactive GnRH agonistJ Gerris, Y Jacquemyn, E Desmedt, et al.
Fertility and Sterility|March 1, 1991
Placebo-controlled trial of high-dose Mesterolone treatment of idiopathic male infertilityJ Gerris, F Comhaire, P Hellemans, et al.
Facts, Views & Vision in Obgyn|December 7, 2017
Correlation between saliva and serum concentrations of estradiol in women undergoing ovarian hyperstimulation with gonadotropins for IVF/ICSIC Dielen, T Fiers, S Somers, et al.
Human Reproduction (Oxford, England)|August 10, 2004
Placenta percreta causing rupture of an unscarred uterus at the end of the first trimester of pregnancy: case reportA Esmans, J Gerris, E Corthout, et al.
Human Reproduction (Oxford, England)|October 1, 1993
Triggering of ovulation using a gonadotrophin-releasing hormone agonist does not prevent ovarian hyperstimulation syndromeS van der Meer, J Gerris, M Joostens, et al.
Human Reproduction (Oxford, England)|January 1, 1995
Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU)J Gerris, A De Vits, M Joostens, et al.
Acta Anaesthesiologica Belgica|June 1, 1983
Anesthesiological problems related to the use of beta-sympathomimetic drugs for chronic and acute tocolysisJ Gerris, G Van Den Abeele, A M Behiels, et al.
Facts, Views & Vision in Obgyn|April 23, 2014
Prevalence of chromosomal abnormalities and timing of karyotype analysis in patients with recurrent implantation failure (RIF) following assisted reproductionP De Sutter, R Stadhouders, M Dutré, et al.
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|March 22, 2003
[Prevention of twin pregnancy after IVF/ICSI using embryo transfer]D De Neubourg, J Gerris, E Van Royen, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|September 9, 2009
Cytology of the 'penile' neovagina in transsexual womenS Weyers, K Lambein, Y Sturtewagen, et al.
Pageof 10